|
G
|
Afp
|
alpha-fetoprotein
|
affects binding
|
EXP
|
Masoprocol binds to AFP protein
|
CTD |
PMID:23013281 PMID:25349334 |
|
NCBI chr14:17,857,584...17,875,645
Ensembl chr14:17,857,584...17,875,649
|
|
G
|
Akt1
|
AKT serine/threonine kinase 1
|
decreases phosphorylation
|
ISO
|
Masoprocol results in decreased phosphorylation of AKT1 protein
|
CTD |
PMID:19503098 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
|
|
G
|
Alk
|
ALK receptor tyrosine kinase
|
multiple interactions decreases activity
|
ISO
|
Masoprocol affects the phosphorylation of and affects the activity of ALK protein mutant form Masoprocol results in decreased activity of ALK protein
|
CTD |
PMID:19503098 |
|
NCBI chr 6:28,631,431...29,351,321
Ensembl chr 6:28,632,197...29,349,721
|
|
G
|
Alox12
|
arachidonate 12-lipoxygenase, 12S type
|
multiple interactions decreases activity
|
ISO EXP
|
Masoprocol inhibits the reaction [ALOX12 protein results in increased chemical synthesis of 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid] Masoprocol results in decreased activity of ALOX12 protein
|
CTD |
PMID:3928952 PMID:6240459 PMID:9258337 PMID:17027136 PMID:23238474 |
|
NCBI chr10:55,456,923...55,469,239
Ensembl chr10:55,456,928...55,469,199
|
|
G
|
Alox15
|
arachidonate 15-lipoxygenase
|
multiple interactions decreases activity
|
EXP ISO
|
Masoprocol inhibits the reaction [[[Oxygen deficiency results in increased activity of ALOX15 protein] which results in increased chemical synthesis of 15-hydroxy-5,8,11,13-eicosatetraenoic acid] which results in decreased expression of KCNA5 mRNA] [Masoprocol results in decreased activity of ALOX15 protein] which results in increased abundance of 13-hydroxy-9,11-octadecadienoic acid
|
CTD |
PMID:15574791 PMID:18984061 |
|
NCBI chr10:55,559,060...55,567,535
Ensembl chr10:55,559,061...55,567,723
|
|
G
|
Alox5
|
arachidonate 5-lipoxygenase
|
affects response to substance decreases activity multiple interactions
|
ISO EXP
|
ALOX5 protein affects the susceptibility to Masoprocol Masoprocol results in decreased activity of ALOX5 protein [Masoprocol results in decreased activity of ALOX5 protein] which results in decreased chemical synthesis of Leukotriene B4; [Masoprocol results in decreased activity of ALOX5 protein] which results in increased abundance of 15-hydroxy-5,8,11,13-eicosatetraenoic acid; Masoprocol inhibits the reaction [ALOX5 protein promotes the reaction [lysophosphatidic acid results in increased abundance of Hydrogen Peroxide]] Masoprocol inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 mRNA]; Masoprocol inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 protein]
|
CTD |
PMID:2724698 PMID:2849922 PMID:3928952 PMID:6240459 PMID:10698703 PMID:18083043 PMID:19503098 More...
|
|
NCBI chr 4:151,203,948...151,251,126
Ensembl chr 4:151,203,949...151,251,126
|
|
G
|
Ar
|
androgen receptor
|
affects binding
|
EXP
|
Masoprocol binds to AR protein
|
CTD |
PMID:14565775 |
|
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:67,135,317...67,304,467
|
|
G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
increases expression multiple interactions
|
ISO
|
Masoprocol results in increased expression of BAX protein MYC affects the reaction [Masoprocol results in increased expression of BAX protein]
|
CTD |
PMID:15034932 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
G
|
Bid
|
BH3 interacting domain death agonist
|
multiple interactions
|
ISO
|
[Masoprocol co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of BID protein
|
CTD |
PMID:17645780 |
|
NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:155,785,377...155,808,275
|
|
G
|
Casp3
|
caspase 3
|
increases cleavage increases activity multiple interactions
|
ISO EXP
|
Masoprocol results in increased cleavage of CASP3 protein Masoprocol results in increased activity of CASP3 protein [Masoprocol co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP3 protein acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Masoprocol results in increased activity of CASP3 protein]; Masoprocol inhibits the reaction [FASL protein results in increased activity of CASP3 protein] Masoprocol inhibits the reaction [pentaacetyl geniposide results in increased cleavage of and results in increased activity of CASP3 protein]; Masoprocol inhibits the reaction [pentaacetyl geniposide results in increased expression of CASP3 protein]
|
CTD |
PMID:10203695 PMID:10653524 PMID:11470254 PMID:15034932 PMID:17645780 PMID:17651887 PMID:18645000 PMID:19503098 PMID:22308955 More...
|
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
G
|
Casp8
|
caspase 8
|
multiple interactions increases expression
|
ISO
|
[Masoprocol co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP8 protein Masoprocol results in increased expression of CASP8 protein Masoprocol inhibits the reaction [FASL protein results in increased activity of CASP8 protein]
|
CTD |
PMID:10203695 PMID:17645780 |
|
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699
|
|
G
|
Casp9
|
caspase 9
|
increases activity
|
ISO
|
Masoprocol results in increased activity of CASP9 protein
|
CTD |
PMID:15034932 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
G
|
Ccl5
|
C-C motif chemokine ligand 5
|
multiple interactions
|
EXP
|
Masoprocol inhibits the reaction [[Calcimycin co-treated with CCL5 protein] results in increased secretion of Leukotriene B4]; Masoprocol inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 mRNA]; Masoprocol inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 protein]
|
CTD |
PMID:18083043 |
|
NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,738,651...68,824,884
|
|
G
|
Ccnd1
|
cyclin D1
|
decreases expression
|
ISO
|
Masoprocol results in decreased expression of CCND1 protein
|
CTD |
PMID:11953870 |
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
|
|
G
|
Cdh1
|
cadherin 1
|
decreases methylation increases expression
|
ISO
|
Masoprocol results in decreased methylation of CDH1 promoter Masoprocol results in increased expression of CDH1 mRNA; Masoprocol results in increased expression of CDH1 protein
|
CTD |
PMID:18418215 |
|
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565
|
|
G
|
Cdkn2a
|
cyclin-dependent kinase inhibitor 2A
|
decreases methylation increases expression
|
ISO
|
Masoprocol results in decreased methylation of CDKN2A promoter Masoprocol results in increased expression of CDKN2A mRNA; Masoprocol results in increased expression of CDKN2A protein
|
CTD |
PMID:18164318 |
|
NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:109,100,772...109,119,248
|
|
G
|
Chuk
|
component of inhibitor of nuclear factor kappa B kinase complex
|
multiple interactions
|
ISO
|
Masoprocol inhibits the reaction [FN1 protein modified form results in increased expression of CHUK protein modified form]
|
CTD |
PMID:17395008 |
|
NCBI chr 1:252,908,748...252,944,273
Ensembl chr 1:252,908,749...252,944,273
|
|
G
|
Cryab
|
crystallin, alpha B
|
multiple interactions
|
EXP
|
Masoprocol promotes the reaction [sodium arsenite results in increased expression of CRYAB mRNA]; Masoprocol promotes the reaction [sodium arsenite results in increased expression of CRYAB protein]
|
CTD |
PMID:8591993 |
|
NCBI chr 8:59,989,885...59,995,532
Ensembl chr 8:59,989,814...59,995,528
|
|
G
|
Dio1
|
iodothyronine deiodinase 1
|
decreases activity
|
ISO
|
Masoprocol results in decreased activity of DIO1 protein
|
CTD |
PMID:30561685 |
|
NCBI chr 5:127,303,089...127,319,784
Ensembl chr 5:127,303,083...127,319,771
|
|
G
|
Dio2
|
iodothyronine deiodinase 2
|
decreases activity
|
ISO
|
Masoprocol results in decreased activity of DIO2 protein
|
CTD |
PMID:30561685 |
|
NCBI chr 6:115,396,308...115,410,594
Ensembl chr 6:115,396,308...115,410,594
|
|
G
|
Dio3
|
iodothyronine deiodinase 3
|
decreases activity
|
ISO
|
Masoprocol results in decreased activity of DIO3 protein
|
CTD |
PMID:30561685 |
|
NCBI chr 6:135,107,072...135,108,933
Ensembl chr 6:135,107,074...135,107,985
|
|
G
|
Erbb2
|
erb-b2 receptor tyrosine kinase 2
|
multiple interactions
|
ISO
|
Masoprocol inhibits the reaction [IGF1 protein results in increased phosphorylation of ERBB2 protein]
|
CTD |
PMID:18645000 |
|
NCBI chr10:83,907,491...83,931,365
Ensembl chr10:83,907,460...83,931,481
|
|
G
|
Esr1
|
estrogen receptor 1
|
multiple interactions
|
ISO
|
Masoprocol binds to and results in increased activity of ESR1 protein
|
CTD |
PMID:19063592 |
|
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
|
|
G
|
Fas
|
Fas cell surface death receptor
|
increases expression
|
ISO
|
Masoprocol results in increased expression of FAS protein
|
CTD |
PMID:17645780 |
|
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104
|
|
G
|
Faslg
|
Fas ligand
|
multiple interactions
|
ISO EXP
|
Masoprocol inhibits the reaction [FASL protein results in increased activity of CASP3 protein]; Masoprocol inhibits the reaction [FASL protein results in increased activity of CASP8 protein] Masoprocol inhibits the reaction [pentaacetyl geniposide results in increased expression of FASLG protein]
|
CTD |
PMID:10203695 PMID:17651887 |
|
NCBI chr13:76,680,885...76,706,042
Ensembl chr13:76,688,243...76,695,503
|
|
G
|
Fn1
|
fibronectin 1
|
multiple interactions
|
ISO
|
Masoprocol inhibits the reaction [FN1 protein modified form results in increased expression of and results in increased secretion of MMP13 protein]; Masoprocol inhibits the reaction [FN1 protein modified form results in increased expression of CHUK protein modified form]; Masoprocol inhibits the reaction [FN1 protein modified form results in increased expression of MAPK8 protein modified form]; Masoprocol inhibits the reaction [FN1 protein modified form results in increased expression of MAPK9 protein modified form]; Masoprocol inhibits the reaction [FN1 protein modified form results in increased expression of NFKBIA protein modified form]; Masoprocol inhibits the reaction [FN1 protein modified form results in increased expression of RELA protein modified form]; Masoprocol inhibits the reaction [FN1 protein modified form results in increased phosphorylation of MAPK1 protein]; Masoprocol inhibits the reaction [FN1 protein modified form results in increased phosphorylation of MAPK3 protein]
|
CTD |
PMID:17395008 |
|
NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:80,645,507...80,714,137
|
|
G
|
Fos
|
Fos proto-oncogene, AP-1 transcription factor subunit
|
multiple interactions
|
ISO
|
Masoprocol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of [FOS protein co-treated with JUN protein]]
|
CTD |
PMID:10692565 |
|
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
|
|
G
|
Fpr1
|
formyl peptide receptor 1
|
decreases activity
|
ISO
|
Masoprocol results in decreased activity of FPR1 protein
|
CTD |
PMID:17520823 |
|
NCBI chr 1:67,417,991...67,429,813
Ensembl chr 1:67,421,313...67,422,520
|
|
G
|
Hmox1
|
heme oxygenase 1
|
increases expression
|
EXP ISO
|
Masoprocol results in increased expression of HMOX1 mRNA; Masoprocol results in increased expression of HMOX1 protein
|
CTD |
PMID:18852027 PMID:23942037 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
G
|
Hsd11b2
|
hydroxysteroid 11-beta dehydrogenase 2
|
multiple interactions increases activity increases expression
|
ISO
|
12-Hydroxy-5,8,10,14-eicosatetraenoic Acid inhibits the reaction [Masoprocol results in increased activity of HSD11B2 protein]; 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid inhibits the reaction [Masoprocol results in increased expression of HSD11B2 mRNA]; [Masoprocol co-treated with 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid] results in decreased expression of HSD11B2 protein; [Masoprocol co-treated with Leukotriene B4] results in decreased expression of HSD11B2 protein; Leukotriene B4 inhibits the reaction [Masoprocol results in increased activity of HSD11B2 protein]; Masoprocol inhibits the reaction [Progesterone results in decreased activity of HSD11B2 protein]; Masoprocol promotes the reaction [Mifepristone results in increased activity of HSD11B2 protein]
|
CTD |
PMID:10377029 PMID:18032417 |
|
NCBI chr19:50,307,569...50,312,812
Ensembl chr19:50,307,569...50,312,812
|
|
G
|
Igf1
|
insulin-like growth factor 1
|
multiple interactions
|
ISO
|
Masoprocol inhibits the reaction [IGF1 protein promotes the reaction [IGF1R protein results in increased phosphorylation of and results in increased activity of IGF1R protein]]; Masoprocol inhibits the reaction [IGF1 protein results in increased phosphorylation of ERBB2 protein]; Masoprocol inhibits the reaction [IGF1 protein results in increased phosphorylation of IGF1R protein]
|
CTD |
PMID:18491370 PMID:18645000 |
|
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764
|
|
G
|
Igf1r
|
insulin-like growth factor 1 receptor
|
multiple interactions decreases activity
|
ISO
|
Masoprocol inhibits the reaction [Dihydrotestosterone results in increased expression of IGF1R mRNA]; Masoprocol inhibits the reaction [Dihydrotestosterone results in increased expression of IGF1R protein]; Masoprocol inhibits the reaction [IGF1 protein promotes the reaction [IGF1R protein results in increased phosphorylation of and results in increased activity of IGF1R protein]]; Masoprocol inhibits the reaction [IGF1 protein results in increased phosphorylation of IGF1R protein] Masoprocol results in decreased activity of IGF1R protein
|
CTD |
PMID:18491370 PMID:18645000 |
|
NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:130,959,997...131,248,664
|
|
G
|
Il1b
|
interleukin 1 beta
|
multiple interactions decreases response to substance
|
ISO
|
Masoprocol inhibits the reaction [Eicosapentaenoic Acid inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein]]; Masoprocol inhibits the reaction [IL1B protein results in increased expression of MMP13 mRNA]; Masoprocol inhibits the reaction [IL1B protein results in increased expression of MMP13 protein] Masoprocol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] Masoprocol results in decreased susceptibility to IL1B protein
|
CTD |
PMID:8186192 PMID:12573452 PMID:21211511 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
G
|
Il6
|
interleukin 6
|
multiple interactions
|
ISO
|
Masoprocol inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]
|
CTD |
PMID:8186192 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
G
|
Iyd
|
iodotyrosine deiodinase
|
multiple interactions
|
ISO
|
Masoprocol inhibits the reaction [IYD protein results in increased metabolism of Monoiodotyrosine]
|
CTD |
PMID:33352258 |
|
NCBI chr 1:42,410,099...42,425,414
Ensembl chr 1:42,410,130...42,426,386
|
|
G
|
Jun
|
Jun proto-oncogene, AP-1 transcription factor subunit
|
decreases expression multiple interactions
|
ISO
|
Masoprocol results in decreased expression of JUN mRNA Masoprocol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of [FOS protein co-treated with JUN protein]]
|
CTD |
PMID:10692565 PMID:15034932 |
|
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285
|
|
G
|
Kcna5
|
potassium voltage-gated channel subfamily A member 5
|
multiple interactions
|
EXP
|
Masoprocol inhibits the reaction [[[Oxygen deficiency results in increased activity of ALOX15 protein] which results in increased chemical synthesis of 15-hydroxy-5,8,11,13-eicosatetraenoic acid] which results in decreased expression of KCNA5 mRNA]
|
CTD |
PMID:18984061 |
|
NCBI chr 4:161,040,853...161,044,311
Ensembl chr 4:160,996,950...161,044,408
|
|
G
|
Krt1
|
keratin 1
|
multiple interactions
|
ISO
|
Masoprocol inhibits the reaction [Calcium results in increased expression of KRT1 mRNA]
|
CTD |
PMID:12069687 |
|
NCBI chr 7:134,855,311...134,860,537
Ensembl chr 7:134,855,313...134,860,537
|
|
G
|
Lhb
|
luteinizing hormone subunit beta
|
multiple interactions
|
EXP
|
Masoprocol inhibits the reaction [LHB protein results in increased abundance of Cyclic AMP]; Masoprocol inhibits the reaction [LHB protein results in increased abundance of Pregnenolone]; Masoprocol inhibits the reaction [LHB protein results in increased abundance of Testosterone]
|
CTD |
PMID:6430271 |
|
NCBI chr 1:105,037,457...105,038,446
Ensembl chr 1:105,037,457...105,038,445
|
|
G
|
Mapk1
|
mitogen activated protein kinase 1
|
multiple interactions decreases phosphorylation
|
ISO
|
Masoprocol inhibits the reaction [FN1 protein modified form results in increased phosphorylation of MAPK1 protein] Masoprocol results in decreased phosphorylation of MAPK1 protein
|
CTD |
PMID:17395008 PMID:19503098 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
G
|
Mapk3
|
mitogen activated protein kinase 3
|
decreases phosphorylation multiple interactions
|
ISO
|
Masoprocol results in decreased phosphorylation of MAPK3 protein Masoprocol inhibits the reaction [FN1 protein modified form results in increased phosphorylation of MAPK3 protein]
|
CTD |
PMID:17395008 PMID:19503098 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
G
|
Mapk8
|
mitogen-activated protein kinase 8
|
multiple interactions
|
ISO
|
Masoprocol inhibits the reaction [FN1 protein modified form results in increased expression of MAPK8 protein modified form]
|
CTD |
PMID:17395008 |
|
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427
|
|
G
|
Mapk9
|
mitogen-activated protein kinase 9
|
multiple interactions
|
ISO
|
Masoprocol inhibits the reaction [FN1 protein modified form results in increased expression of MAPK9 protein modified form]
|
CTD |
PMID:17395008 |
|
NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,670,756...34,712,228
|
|
G
|
Mmp13
|
matrix metallopeptidase 13
|
multiple interactions
|
ISO
|
Masoprocol inhibits the reaction [FN1 protein modified form results in increased expression of and results in increased secretion of MMP13 protein]; Masoprocol inhibits the reaction [IL1B protein results in increased expression of MMP13 mRNA]; Masoprocol inhibits the reaction [IL1B protein results in increased expression of MMP13 protein]; Masoprocol inhibits the reaction [TNF protein results in increased expression of MMP13 mRNA]; Masoprocol inhibits the reaction [TNF protein results in increased expression of MMP13 protein]
|
CTD |
PMID:17395008 PMID:21211511 |
|
NCBI chr 8:12,782,829...12,793,108
Ensembl chr 8:12,782,813...12,793,105
|
|
G
|
Myc
|
MYC proto-oncogene, bHLH transcription factor
|
increases expression multiple interactions
|
ISO
|
Masoprocol results in increased expression of MYC protein MYC affects the reaction [Masoprocol results in increased expression of BAX protein]; MYC affects the reaction [Masoprocol results in increased expression of MYC protein]; MYC affects the reaction [Masoprocol results in increased expression of TP53 protein]
|
CTD |
PMID:15034932 |
|
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028
|
|
G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
multiple interactions
|
EXP
|
Masoprocol affects the localization of and results in increased activity of NFE2L2 protein
|
CTD |
PMID:18852027 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
|
|
G
|
Nfkbia
|
NFKB inhibitor alpha
|
multiple interactions
|
ISO
|
Masoprocol inhibits the reaction [FN1 protein modified form results in increased expression of NFKBIA protein modified form]
|
CTD |
PMID:17395008 |
|
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072
|
|
G
|
Ngf
|
nerve growth factor
|
multiple interactions
|
EXP
|
Masoprocol inhibits the reaction [pentaacetyl geniposide results in increased expression of NGF mRNA]; Masoprocol inhibits the reaction [pentaacetyl geniposide results in increased expression of NGF protein]
|
CTD |
PMID:17651887 |
|
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:192,589,582...192,643,834
|
|
G
|
Ngfr
|
nerve growth factor receptor
|
multiple interactions
|
EXP
|
Masoprocol inhibits the reaction [pentaacetyl geniposide results in increased expression of NGFR mRNA]; Masoprocol inhibits the reaction [pentaacetyl geniposide results in increased expression of NGFR protein]
|
CTD |
PMID:17651887 |
|
NCBI chr10:81,012,077...81,030,305
Ensembl chr10:81,012,089...81,030,305
|
|
G
|
Nos3
|
nitric oxide synthase 3
|
multiple interactions
|
ISO
|
Masoprocol inhibits the reaction [Ritonavir results in decreased expression of NOS3 mRNA]
|
CTD |
PMID:22037733 |
|
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664
|
|
G
|
Npy
|
neuropeptide Y
|
multiple interactions
|
ISO
|
Masoprocol affects the reaction [bisphenol A affects the expression of NPY mRNA]
|
CTD |
PMID:32960947 |
|
NCBI chr 4:80,212,111...80,219,310
Ensembl chr 4:80,212,111...80,219,310
|
|
G
|
Odc1
|
ornithine decarboxylase 1
|
multiple interactions
|
ISO
|
Masoprocol inhibits the reaction [Benzoyl Peroxide results in increased activity of ODC1 protein]
|
CTD |
PMID:2105358 |
|
NCBI chr 6:46,058,439...46,065,148
Ensembl chr 6:46,058,463...46,065,146
|
|
G
|
Otc
|
ornithine transcarbamylase
|
multiple interactions
|
EXP
|
Masoprocol promotes the reaction [PRL protein results in increased activity of OTC protein]
|
CTD |
PMID:3097147 |
|
NCBI chr X:15,126,358...15,202,473
Ensembl chr X:15,126,358...15,239,555
|
|
G
|
Pcna
|
proliferating cell nuclear antigen
|
multiple interactions
|
ISO
|
Masoprocol affects the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] affects the expression of PCNA protein]
|
CTD |
PMID:25770929 |
|
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901
|
|
G
|
Por
|
cytochrome p450 oxidoreductase
|
multiple interactions
|
ISO
|
Masoprocol inhibits the reaction [POR protein affects the reaction [Benzo(a)pyrene results in increased chemical synthesis of benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide-DNA]]
|
CTD |
PMID:28111842 |
|
NCBI chr12:26,587,674...26,655,612
Ensembl chr12:26,587,674...26,635,809
|
|
G
|
Prl
|
prolactin
|
multiple interactions
|
EXP
|
Masoprocol promotes the reaction [PRL protein results in increased activity of OTC protein]
|
CTD |
PMID:3097147 |
|
NCBI chr17:38,287,355...38,298,234
Ensembl chr17:38,288,162...38,298,217
|
|
G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
multiple interactions
|
ISO
|
Masoprocol inhibits the reaction [Eicosapentaenoic Acid inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein]]; Masoprocol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]
|
CTD |
PMID:7575673 PMID:12573452 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
G
|
Rb1
|
RB transcriptional corepressor 1
|
decreases phosphorylation
|
ISO
|
Masoprocol results in decreased phosphorylation of RB1 protein
|
CTD |
PMID:18164318 |
|
NCBI chr15:54,780,858...54,911,989
Ensembl chr15:54,780,858...54,911,857
|
|
G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
multiple interactions
|
ISO
|
Masoprocol inhibits the reaction [FN1 protein modified form results in increased expression of RELA protein modified form]
|
CTD |
PMID:17395008 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
G
|
Shbg
|
sex hormone binding globulin
|
affects binding
|
ISO
|
Masoprocol binds to SHBG protein
|
CTD |
PMID:25349334 |
|
NCBI chr10:54,831,716...54,849,162
Ensembl chr10:54,831,718...54,838,760
|
|
G
|
Slc5a5
|
solute carrier family 5 member 5
|
multiple interactions
|
EXP
|
Masoprocol inhibits the reaction [TSHB protein results in increased expression of SLC5A5 mRNA]
|
CTD |
PMID:17962351 |
|
NCBI chr16:18,580,705...18,590,692
Ensembl chr16:18,580,705...18,590,691
|
|
G
|
Sod2
|
superoxide dismutase 2
|
multiple interactions
|
ISO
|
Masoprocol inhibits the reaction [Arachidonic Acid results in increased expression of SOD2 mRNA]; Masoprocol inhibits the reaction [Arachidonic Acid results in increased expression of SOD2 protein]; Masoprocol inhibits the reaction [TNF protein results in increased expression of SOD2 mRNA]
|
CTD |
PMID:8760145 PMID:12031898 |
|
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
|
|
G
|
Stat3
|
signal transducer and activator of transcription 3
|
decreases phosphorylation
|
ISO
|
Masoprocol results in decreased phosphorylation of STAT3 protein
|
CTD |
PMID:19503098 |
|
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359
|
|
G
|
Tgfb1
|
transforming growth factor, beta 1
|
multiple interactions
|
EXP
|
Masoprocol inhibits the reaction [Puromycin Aminonucleoside results in increased expression of TGFB1 mRNA]
|
CTD |
PMID:19194550 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
|
|
G
|
Tnf
|
tumor necrosis factor
|
multiple interactions decreases response to substance
|
ISO
|
Masoprocol inhibits the reaction [TNF protein results in increased expression of MMP13 mRNA]; Masoprocol inhibits the reaction [TNF protein results in increased expression of MMP13 protein]; Masoprocol inhibits the reaction [TNF protein results in increased expression of SOD2 mRNA] Masoprocol results in decreased susceptibility to TNF protein Masoprocol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]
|
CTD |
PMID:8186192 PMID:8760145 PMID:21211511 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
G
|
Tnfsf10
|
TNF superfamily member 10
|
multiple interactions
|
ISO
|
[Masoprocol co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of BID protein; [Masoprocol co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP10 protein; [Masoprocol co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP3 protein; [Masoprocol co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP8 protein
|
CTD |
PMID:17645780 |
|
NCBI chr 2:112,136,550...112,155,903
|
|
G
|
Tp53
|
tumor protein p53
|
multiple interactions increases expression
|
ISO
|
MYC affects the reaction [Masoprocol results in increased expression of TP53 protein]
|
CTD |
PMID:15034932 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
G
|
Trpv1
|
transient receptor potential cation channel, subfamily V, member 1
|
multiple interactions
|
EXP
|
Masoprocol inhibits the reaction [[Melitten results in increased activity of TRPV1 protein] which results in increased transport of Calcium]
|
CTD |
PMID:21453681 |
|
NCBI chr10:58,349,936...58,375,021
Ensembl chr10:58,340,223...58,375,021
|
|
G
|
Tshb
|
thyroid stimulating hormone subunit beta
|
multiple interactions
|
EXP
|
Masoprocol inhibits the reaction [TSHB protein results in increased expression of SLC5A5 mRNA]
|
CTD |
PMID:17962351 |
|
NCBI chr 2:192,913,171...192,918,054
Ensembl chr 2:192,913,171...192,942,984
|
|
G
|
Ugt1a1
|
UDP glucuronosyltransferase family 1 member A1
|
increases glucuronidation
|
ISO
|
UGT1A1 protein results in increased glucuronidation of Masoprocol
|
CTD |
PMID:14557274 |
|
NCBI chr 9:96,249,143...96,256,264
Ensembl chr 9:96,144,786...96,256,264
|
|
G
|
Ugt1a9
|
UDP glucuronosyltransferase family 1 member A9
|
increases glucuronidation
|
ISO
|
UGT1A9 protein results in increased glucuronidation of Masoprocol
|
CTD |
PMID:14557274 |
|
NCBI chr 9:96,144,786...96,256,264
Ensembl chr 9:96,144,786...96,256,264
|
|
G
|
Vegfa
|
vascular endothelial growth factor A
|
multiple interactions
|
ISO
|
Masoprocol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of VEGFA mRNA]; Masoprocol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased secretion of VEGFA protein]
|
CTD |
PMID:17520823 |
|
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
|
|